Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Sep;33(9):1617–1619. doi: 10.1128/aac.33.9.1617

Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

W H Traub 1, M Spohr 1
PMCID: PMC172714  PMID: 2817859

Abstract

A total of 144 clinical isolates of Acinetobacter species, i.e., A. baumannii (n = 60), genospecies 3 (n = 48), A. haemolyticus (n = 12), and genospecies 6 (n = 24), were examined comparatively with the agar dilution method of the National Committee for Clinical Laboratory Standards for susceptibility to 25 antimicrobial drugs. Only minor species differences were noted.

Full text

PDF
1617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrutyn E., Goodhart G. L., Roos K., Anderson R., Buxton A. Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis. Am J Epidemiol. 1978 Apr;107(4):328–335. doi: 10.1093/oxfordjournals.aje.a112548. [DOI] [PubMed] [Google Scholar]
  2. Appelbaum P. C., Tamim J., Stavitz J., Aber R. C. Sensitivity of Acinetobacter calcoaceticus strains to seven cephalosporins. Lancet. 1981 Aug 29;2(8244):472–472. doi: 10.1016/s0140-6736(81)90802-3. [DOI] [PubMed] [Google Scholar]
  3. Bergogne-Berezin E., Joly-Guillou M. L. An underestimated nosocomial pathogen, Acinetobacter calcoaceticus. J Antimicrob Chemother. 1985 Nov;16(5):535–538. doi: 10.1093/jac/16.5.535. [DOI] [PubMed] [Google Scholar]
  4. Bouvet P. J., Grimont P. A. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol. 1987 Sep-Oct;138(5):569–578. doi: 10.1016/0769-2609(87)90042-1. [DOI] [PubMed] [Google Scholar]
  5. Buxton A. E., Anderson R. L., Werdegar D., Atlas E. Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics. Am J Med. 1978 Sep;65(3):507–513. doi: 10.1016/0002-9343(78)90777-5. [DOI] [PubMed] [Google Scholar]
  6. Castle M., Tenney J. H., Weinstein M. P., Eickhoff T. C. Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control. Heart Lung. 1978 Jul-Aug;7(4):641–644. [PubMed] [Google Scholar]
  7. Chow A. W., Wong J., Bartlett K. H. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus. Diagn Microbiol Infect Dis. 1988 Apr;9(4):213–217. doi: 10.1016/0732-8893(88)90111-3. [DOI] [PubMed] [Google Scholar]
  8. Crues J. V., 3rd, Murray B. E., Moellering R. C., Jr In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus. Antimicrob Agents Chemother. 1979 Nov;16(5):690–692. doi: 10.1128/aac.16.5.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garcia I., Fainstein V., LeBlanc B., Bodey G. P. In vitro activities of new beta-lactam antibiotics against Acinetobacter spp. Antimicrob Agents Chemother. 1983 Aug;24(2):297–299. doi: 10.1128/aac.24.2.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holton J. A report of a further hospital outbreak caused by a multi-resistant Acinetobacter anitratus. J Hosp Infect. 1982 Sep;3(3):305–309. doi: 10.1016/0195-6701(82)90051-2. [DOI] [PubMed] [Google Scholar]
  11. Obana Y., Nishino T., Tanino T. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J Antimicrob Chemother. 1985 Apr;15(4):441–448. doi: 10.1093/jac/15.4.441. [DOI] [PubMed] [Google Scholar]
  12. Overbeek B. P., Rozenberg-Arska M., Verhoef J. Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro. Eur J Clin Microbiol. 1985 Apr;4(2):140–141. doi: 10.1007/BF02013583. [DOI] [PubMed] [Google Scholar]
  13. Ramphal R., Kluge R. M. Acinetobacter calcoaceticus variety anitratus: an increasing nosocomial problem. Am J Med Sci. 1979 Jan-Feb;277(1):57–66. doi: 10.1097/00000441-197901000-00007. [DOI] [PubMed] [Google Scholar]
  14. Rolston K. V., Bodey G. P. In vitro susceptibility of Acinetobacter species to various antimicrobial agents. Antimicrob Agents Chemother. 1986 Nov;30(5):769–770. doi: 10.1128/aac.30.5.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stiver H. G., Bartlett K. H., Chow A. W. Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics. Antimicrob Agents Chemother. 1986 Oct;30(4):624–625. doi: 10.1128/aac.30.4.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ygout J. F., Housset B., Derenne J. P., Daguet G. L. Hospital-acquired Acinetobacter baumanii pneumonitis. Lancet. 1987 Apr 4;1(8536):802–802. doi: 10.1016/s0140-6736(87)92822-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES